These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22651840)

  • 1. Left ventricular assist devices in heart failure.
    Kilic A; Ailawadi G
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):649-56. PubMed ID: 22651840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapy.
    Slaughter MS
    J Card Surg; 2010 Jul; 25(4):490-4. PubMed ID: 20642766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular assist device therapy.
    Sayer G; Naka Y; Jorde UP
    Cardiovasc Ther; 2009; 27(2):140-50. PubMed ID: 19426251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular device as destination therapy: are we there yet?
    Badiwala MV; Rao V
    Curr Opin Cardiol; 2009 Mar; 24(2):184-9. PubMed ID: 19532106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1A time.
    Dardas T; Mokadam NA; Pagani F; Aaronson K; Levy WC
    J Am Coll Cardiol; 2012 Jul; 60(1):36-43. PubMed ID: 22541833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial.
    Dembitsky WP; Tector AJ; Park S; Moskowitz AJ; Gelijns AC; Ronan NS; Piccione W; Holman WL; Furukawa S; Weinberg AD; Heatley G; Poirier VL; Damme L; Long JW
    Ann Thorac Surg; 2004 Dec; 78(6):2123-9; discussion 2129-30. PubMed ID: 15561049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
    Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac recovery during mechanical assist device support.
    Maybaum S; Kamalakannan G; Murthy S
    Semin Thorac Cardiovasc Surg; 2008; 20(3):234-46. PubMed ID: 19038734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial.
    John R; Naka Y; Smedira NG; Starling R; Jorde U; Eckman P; Farrar DJ; Pagani FD
    Ann Thorac Surg; 2011 Oct; 92(4):1406-13; discussion 1413. PubMed ID: 21958789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices.
    Argenziano M; Catanese KA; Moazami N; Gardocki MT; Weinberg AD; Clavenna MW; Rose EA; Scully BE; Levin HR; Oz MC
    J Heart Lung Transplant; 1997 Aug; 16(8):822-31. PubMed ID: 9286774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.
    Dang NC; Topkara VK; Mercando M; Kay J; Kruger KH; Aboodi MS; Oz MC; Naka Y
    J Heart Lung Transplant; 2006 Jan; 25(1):1-6. PubMed ID: 16399523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
    J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacotherapy of the HeartMate II, a continuous flow left ventricular assist device, in patients with advanced heart failure: integration of disease, device, and drug.
    Jennings DL; Chambers RM; Schillig JM
    Ann Pharmacother; 2010 Oct; 44(10):1647-50. PubMed ID: 20841512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.